-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Aspire Biopharma Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q3 2025.
- Aspire Biopharma Holdings, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$705K, a 852% decline year-over-year.
- Aspire Biopharma Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$11.8M, a 4026% decline year-over-year.
- Aspire Biopharma Holdings, Inc. annual Nonoperating Income (Expense) for 2024 was -$9.45M, a 263% decline from 2023.
- Aspire Biopharma Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was $5.8M, a 34.5% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)